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Summary
Increased ligand binding to cellular integrins (‘‘activation’’)
plays important roles in processes such as development,
cell migration, extracellular matrix assembly, tumor metas-
tasis, hemostasis, and thrombosis [1–5]. Integrin activation
encompasses both increased integrin monomer affinity
and increased receptor clustering [6] and depends on
integrin-talin interactions [5]. Loss of kindlins results in
reduced activation of integrins [7–13]. Kindlins might pro-
mote talin binding to integrins through a cooperative mech-
anism [5, 14–16]; however, kindlins do not increase talin
association with integrins [17]. Here, we report that, unlike
talin head domain (THD), kindlin-3 has little effect on the
affinity of purified monomeric aIIbb3, and it does not
enhance activation by THD. Furthermore, studies with li-
gands of varying valency show that kindlins primarily
increase cellular aIIbb3 avidity rather thanmonomer affinity.
In platelets or nucleated cells, loss of kindlins markedly
reduces aIIbb3 binding to multivalent but not monovalent
ligands. Finally, silencing of kindlins reduces the clustering
of ligand-occupied aIIbb3 as revealed by total internal
reflection fluorescence and electron microscopy. Thus, in
contrast to talins, kindlins have little primary effect on in-
tegrin aIIbb3 affinity for monovalent ligands and increase
multivalent ligand binding by promoting the clustering of
talin-activated integrins.Results
Kindlin-3 Has a Minimal Effect on the Affinity of Monomeric
aIIbb3
To assess the effect of kindlins on individual integrins, we
added purified kindlin-3, the isoform in platelets, to mono-
meric platelet integrin aIIbb3 inserted in 10–12 nm diameter
phospholipid bilayers (nanodiscs) [18]. Since aIIbb3 clustering
cannot occur under these conditions, ligand bindingmeasures
the affinity of integrin monomers [18]. Recombinant purified
kindlin-3 was monomeric (see Figure S1A available online)
and was well folded as judged by a sharp melting point
(48C) in differential scanning calorimetry (data not shown).
Kindlin-3, at a concentration that saturated b3 integrin binding4Present address: Division of Surgical Research, Alpert Medical School,
Brown University, Providence, RI 02903, USA
*Correspondence: mhginsberg@ucsd.edu[14, 17], was >25-fold less active than talin head domain (THD)
in increasing binding of PAC1, an activation-specific antibody,
to aIIbb3 nanodiscs, and it failed to enhance PAC1 binding
induced by THD (Figures 1A and S1B). Indeed, kindlin-3
reduced THD-induced PAC1 binding, possibly due to compe-
tition between THD and kindlin-3 for binding to the limited lipid
surface present in the nanodiscs, rather than to the b3 integrin
[14, 17]. Recombinant kindlin-3 bound to the b3 cytoplasmic
domain (Kd = 676 9 nM), but not to a kindlin binding-defective
b3mutant [b3(Y759A); Figure S1C]. Kindlin-3 also bound aIIbb3
nanodiscs (Figure S1D). Thus, in contrast to THD, recombinant
kindlin-3 did not increase the ligand-binding affinity of mono-
meric aIIbb3 in nanodiscs.
Kindlins Selectively Increase the Binding of Multivalent
Ligands to Recombinant Integrin aIIbb3
The foregoing results suggest that kindlin-3may regulate ligand
binding to integrins by a mechanism other than modulation of
monomer affinity. Platelet activation clusters integrin aIIbb3,
and aIIbb3 dimerization can cooperate with increased mono-
mer affinity to increase thebinding ofmultivalent but notmono-
valent ligands [6, 20, 21]. These observations led us to compare
the effects of kindlins on the binding of multivalent versus
monovalent ligands. Kindlin-1 and kindlin-2 are thought to pro-
mote aIIbb3 activation in nonhematopoietic cells via a mecha-
nism similar to that of kindlin-3 in platelets and are thus used
to study aIIbb3 regulation in such cells [11–13, 22]. Kindlin-1
did not synergize with THD to increase monovalent PAC1 Fab
binding to integrin aIIbb3 in HEK293 cells but dramatically
increasedTHD-inducedbindingofdecavalentPAC1(Figure1B).
To extend this finding, we used the monovalent fibronectin
tenth type III repeat (3FN10), an activation-dependent ligand
for integrin aIIbb3 [23], because it can be expressed in prokary-
otic systems at the high concentrations required for this exper-
iment, can be directly labeled (e.g., with biotin), and binds to
murineaIIbb3. Again, kindlin-1 did not synergizewith THD to in-
crease the specific binding of 3FN10 to integrin aIIbb3,
measured as binding inhibitable by an aIIbb3-specific antago-
nist, eptifibatide (Figures 1C and S1E). 3FN10 binding was not
maximal in the THD-transfected cells, because addition of
Mn2+ markedly increased binding (Figure 1C). Mn2+ enhanced
THD-induced 3FN10 binding, indicating that Mn2+ binding to
the extracellular domain can synergize with talin to increase in-
tegrinmonomer affinity. In sharpcontrast to resultswith 3FN10,
kindlin-1markedlysynergized [13,22]withTHD in thebindingof
decavalent PAC1 immunoglobulin M (IgM) (Figures 1C and
S1E). The increase of PAC1 binding upon THD expression
was greater than that observed with monomeric 3FN10, prob-
ably reflecting both the clustering [24] and conformational
changes [18] of aIIbb3 induced by THD.
To directly test the role of ligand valency in 3FN10 binding,
we chemically crosslinked 3FN10 and isolated a mixed
population of oligomers. In contrast to monovalent 3FN10 or
GST-3FN10, kindlin-1 and kindlin-2 markedly increased the
capacity of THD to enhance the specific binding of multivalent
GST-3FN10 to aIIbb3 (Figure 1D). Mutation of the RGD
sequence in 3FN10 to AAA abolished the binding of both
monomeric and oligomeric 3FN10 (Figure S1F), confirming its
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Figure 1. Kindlins Selectively Increase the Binding of Multivalent Ligands to Recombinant Integrin aIIbb3 Cells, but Not to Monomeric Integrins, in
Nanodiscs
(A) Activation of aIIbb3 in nanodiscs was assayed by PAC1 binding as described in the Supplemental Information. Increase in integrin activation is
calculated as (Li–L0), where Li is the eptifibatide-inhibitable PAC1 binding (luminescence) in the presence of THD (2.5 mM), kindlin-3 (2.5 mM), or
THD+kindlin-3 and L0 is PAC1 binding to integrin nanodiscs alone, which was 535,000 arbitrary units. Error bars indicate 6SEM of three independent
determinations.
(B) HEK293 cells stably expressing aIIbb3 were transfected with cDNA encoding kindlin-1, THD, or kindlin-1+THD. Twenty-four hours after transfection,
cells were harvested, split into three groups, and stained separately with PAC1, PAC1Fab, or D57 (anti-aIIbb3). Cells were then fixed in 3.7% formalde-
hyde. The quantity of PAC1 (decavalent), PAC1Fab (monovalent), or D57 bound was assayed by APC-conjugated anti-IgM (m chain specific) and anti-IgG
and analyzed by flow cytometry. The aIIbb3-specific ligand binding was calculated as described in the Supplemental Information. The right panel
shows the western blots confirming the abundance of expressed proteins in the transfected cells. Error bars indicate 6SEM of three independent
experiments. PAC1 Fab was purified by gel filtration to remove protein aggregates and used at a concentration at least 25-fold higher than that used
by Bunch [19].
(C) HEK293 cells stably expressing aIIbb3were transfected with cDNA encoding kindlin-1, THD, or kindlin-1+THD. The cells were processed as described in
(B), and the binding of PAC1 (decavalent), D57, or 3FN10 (GST removed, monovalent) was assayed. The aIIbb3-specific ligand binding was calculated as
described in the Supplemental Information. Error bars indicate 6SEM of four independent experiments.
(D) HEK293 cells stably expressing aIIbb3were transfected with cDNA encoding kindlin-1, THD, or kindlin-1+THD. The cells were harvested, and the binding
of D57, biotinylated 3FN10 monomer (with GST removed), GST-3FN10, or oligomeric GST-3FN10 was then assayed. Depicted is the aIIbb3-specific ligand
binding as described in the Supplemental Information. Error bars indicate 6SEM of four independent experiments.
Kindlin-Mediated Integrin Activation
2289specificity. The kindlin-induced increase in multivalent ligand
binding was independent of an intact actin cytoskeleton or
myosin II-mediated contractility, as latrunculin A, an inhibitor
of actin polymerization, or blebbistatin, a myosin II ATPase
inhibitor, was without effect (Figure S1G). Thus, kindlins syner-
gized with THD in stimulating the binding of multivalent but not
monovalent ligands to aIIbb3, and this effect required neither
an intact actin cytoskeleton nor myosin II-driven contractility.Silencing of Kindlin-2 Selectively Inhibits the Binding of
Multivalent Ligands to Recombinant Integrin aIIbb3
We then asked whether depletion of kindlins selectively
impairs binding of multivalent integrin ligands. HEK293 cells
express both kindlin-1 and kindlin-2 [25], making it difficult to
perform small interfering RNA (siRNA)-mediated silencing.
Thus, we turned to Chinese hamster ovary (CHO) cells, which
express only kindlin-2 [13, 17]. In CHO cells expressing an
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Figure 2. Depletion of Kindlins Primarily Inhibits the Binding of Multivalent Ligands to Integrin aIIbb3 in Nucleated Cells and in Mouse Platelets
(A) Cells expressing an active aIIbb3(D723R) mutant were transduced with lentivirus expressing a GFP marker and either a scrambled shRNA (control) or
kindlin-2 shRNA1. To confirm the specificity of previously characterized kindlin-2 knockdown constructs [17], we transiently cotransfected shRNA1-
transduced cells with a shRNA-resistant human kindlin-2 and tdTomato as a transfection marker (at a 50:1 ratio of kindlin-2:tomato ). The cells were
then harvested, and binding of anti-aIIbb3 (D57), monomeric 3FN10 (with GST removed), or GST-3FN10 oligomers was used to measure the aIIbb3-specific
ligand binding as described in the Supplemental Information. Error bars indicate 6SEM of three independent experiments. Kindlin-2 expression level was
assessed by immunoblotting as shown in the right panel. The western blot was performed with total cells, whereas the only transduced (GFP-positive) and
transfected (tomato-positive) cells were analyzed for ligand binding by flow cytometry.
(B) Generation of chimeric mice as described in the Supplemental Information. For intracellular flow cytometry, platelets were fixed with 2% formaldehyde,
permeabilized, and stained with rabbit anti-kindlin-3 polyclonal antibody or biotinylated anti-talin monoclonal antibody (clone 8d4). After washing, bound
antibodies were detected with either FITC-anti-rabbit secondary antibody or APC-strepavidin, respectively. The dot plots show the reduced expression of
kindlin-3 and talin1 in DsRed-negative Fermt32/2 and Tln12/2 platelets, respectively.
(C) PAR4-stimulated binding of 3FN10 to platelets. Platelets from irradiatedmice reconstitutedwithmixtures of DsRed-expressing wild-type (WT) and either
Fermt32/2 or Tln12/2 hematopoietic stem cells were incubated in the presence of the indicated concentration of PAR4 agonist peptide or buffer. Eptifiba-
tide-inhibitable specific binding of 3FN10 (with GST removed) to aIIbb3 on DsRed-negative Fermt3–/– or Tln12/2 or DsRed-positive wild-type platelets was
assessed by fluorescence-activated cell sorting (FACS). Cells were separately stained with anti-CD41 (aIIb) to calculate ligand binding as described in the
Supplemental Information. 3FN10 at 100 mg/ml (9.4 mM) was used. In both (C) and (D), error bars indicate SEM (seven chimeric mice for each genotype).
(D) PAR4-stimulated binding of fibrinogen to platelets. In an experiment conducted on the same day as that described in (C), 3FN10 was replaced by
FITC-conjugated fibrinogen.
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2290active aIIbb3(D723R) mutant [26], silencing kindlin-2 inhibited
the binding of oligomeric 3FN10, but it had no effect on
the binding of monovalent 3FN10. This was a specific effect,
as reintroducing small hairpin RNA (shRNA)-resistant
kindlin-2 restored the binding of oligomeric 3FN10 (Fig-
ure 2A). Moreover, kindlin-2 depletion resulted in similar
selective inhibition of oligomeric but not monomeric 3FN10
binding to an active integrin chimera expressed in CHO
cells [27, 28](Figure S2A). Furthermore, adhesion of aIIbb3-
expressing CHO cells to surface-bound 3FN10, which isfunctionally multivalent, was reduced in kindlin-2-silenced
cells (Figure S2B). Thus, kindlin-2 silencing inhibits binding
of multivalent but not monovalent ligands to aIIbb3 ex-
pressed in nucleated cells.
Kindlin-3-Deficient Platelets Are Primarily Defective in
Binding to Multivalent but Not Monovalent aIIbb3 Ligands
Next, we sought to determine how kindlins function in
regulation of aIIbb3 in platelets. Mice lacking kindlin-3 suffer
embryonic and perinatal lethality, recurrent infections, and
Kindlin-Mediated Integrin Activation
2291erythrocyte defects in addition to reduced aIIbb3 functions
[8, 11, 29]. To examine the consequences of loss of kindlin-3,
encoded by the Fermt3 locus, in healthy adult mice, we
reconstituted irradiated mice with kindlin-3 or talin null
hematopoietic cells mixed with wild-type hematopoietic cells
expressing DsRed (Figure 2B). Intracellular staining of iso-
lated platelets indicated that kindlin-3 or talin was depleted
from the respective (DsRed negative) platelet population
(Figure 2B).
PAR4 thrombin receptor agonist peptide stimulated similar
binding of monovalent 3FN10 to aIIbb3 in both kindlin-3 null
and wild-type platelets, whereas loss of platelet talin-1 signif-
icantly inhibited 3FN10 binding (Figure 2C). In contrast, and
as expected [11, 30, 31], loss of either kindlin-3 or talin-1
impaired the binding of multivalent fibrinogen, which has at
least four potential aIIbb3 binding sites (Figure 2D). Further-
more, loss of kindlin-3 had little effect on either fibrinogen
or 3FN10 binding when platelets were activated exogenously
by Mn2+, consistent with previous reports that Mn2+ can pro-
mote both affinity increase [32, 33] and integrin clustering
[24, 34] (Figure S2C). Deletion of talin reduced binding of
3FN10 but not fibrinogen to Mn2+-stimulated platelets (Fig-
ure S2C), suggesting that talin binding synergizes with
Mn2+ in increasing integrin monomer affinity. At higher
agonist concentration (1 mM PAR4 peptide), the defect in
fibrinogen binding to kindlin-3 null platelets was even less
pronounced. To better quantify this result, we examined
binding of various concentrations of 3FN10 to wild-type or
kindlin-3 null platelets. The binding isotherms of 3FN10 to
wild-type and kindlin-3 null platelets virtually overlapped
(Figures S2D and S2F), indicating that a lack of kindlin-3
does not change the affinity of 3FN10 for aIIbb3 on activated
platelets or the capacity of a thrombin receptor agonist
peptide to stimulate increased binding of a monovalent
ligand to aIIbb3 (Figures S2E and S2F). Therefore, in
agonist-stimulated platelets, as in nucleated cells, lack of
kindlin-3 has a major effect on the binding of multivalent
but not monovalent aIIbb3 ligands, whereas lack of talin
has major effects on both ligand types.
Kindlins Promote Clustering of Occupied Integrins
Integrin clustering increases binding of multivalent ligands
without affecting the affinity of integrin aIIbb3 monomers
[6], suggesting that integrin clustering might account for
most of kindlins’ effects. We used total internal reflection
fluorescence (TIRF) microscopy, an established method for
studying clustering [24, 35], to measure aIIbb3 clustering at
the submicron scale. Initial cell adhesion to immobilized
fibrinogen is aIIbb3 activation independent [36, 37], possibly
due to increased ligand density and altered fibrinogen con-
formation [38], enabling us to examine effects of kindlins
independent of their effects on integrin activation per se.
Silencing of kindlin-2 with two different shRNAs significantly
reduced both the brightness and size of integrin puncta (Fig-
ures 3A, 3B, and 3D), even though it had little or no effect on
integrin expression (Figures 3A and 3C). Furthermore,
silencing of kindlin-2 by these shRNAs did not affect the dis-
tance of the plasma membrane from the substrate, since
fluorescence intensity of a membrane-intercalated dye was
equal in control and kindlin-2-silenced cells (Figures S3A
and S3B) in TIRF images.
To assess integrin clustering at the nanoscale, we used
electron microscopy to examine ventral membranes of
fibrinogen-adherent aIIbb3-expressing CHO cells [39]. Incontrol shRNA-transduced cells, we observed numerous clus-
ters, each containing more than five gold particles and usually
less than 200 nm in size, i.e., they account for the point sources
seen in the TIRF images (Figure 4A, left panel). In sharp
contrast, in kindlin-2-silenced cells, gold particles were pre-
sent; however, there were many fewer clusters (Figures 4A,
middle panel, and 4B). The total number of gold particles
was also reduced, likely reflecting an overall decreased abun-
dance of integrins in the ventral membrane. Only occasional
random gold particles were seen in irrelevant IgG-stained
membranes (Figure 4A, right panel). Thus, kindlin-2 promotes
the clustering of ligand-occupied aIIbb3 at the nanoscale.
Kindlins could increase aIIbb3 clustering either before or
after ligand binding. We reasoned that in the latter case,
kindlin-dependent increases in ligand binding would be pre-
vented by fixing the cells before addition of ligand. When cells
were fixed before adding ligands to aIIbb3-expressing HEK293
cells, THD induced a near 3-fold increase in PAC1 binding, but
kindlin-1 failed to synergizewith THD in inducing PAC1binding
(Figure S4A). In contrast, kindlin-1 dramatically increased
THD-induced PAC1 binding in cells fixed after ligand addition
(Figure S4A). Furthermore, consistent with earlier reports that
clustering requires occupancy of the integrin [40], when the
ability of aIIbb3 to bind ligand was blocked by a b3 Asp119
mutation, the integrin remained diffusely distributed as judged
by TIRF microscopy (Figure S4B). Thus, the effect of kindlins
on multivalent ligand binding to integrin aIIbb3 is mediated
by their capacity to promote the clustering of ligand-occupied
aIIbb3.
Discussion
These results pinpoint the locus of kindlin action in mediating
integrin aIIbb3 activation. Earlier studies in invertebrates
[41, 42] and cultured cells [43, 44] showed that kindlins
mediate formation of integrin-mediated adhesions and fore-
shadowed studies showing that kindlins regulate the capacity
of integrins to bind soluble ligands [7, 8, 10, 11, 13] and to pro-
mote integrin signals that regulate the cytoskeleton [12]. Here,
we found that the kindlins increase soluble ligand binding to
aIIbb3 primarily by increasing avidity for multivalent ligands
due to kindlins’ ability to promote clustering of ligand-occu-
pied integrins. Our results now explain why kindlins alone
have little apparent effect on soluble ligand binding to cellular
integrins in the absence of talin-mediated activation and
comport with the finding that kindlin-3 does not induce
changes in b3 transmembrane domain topology, which
induces integrin aIIbb3 activation [45].
We utilized 3FN10 as a monovalent ligand because it binds
to both murine and human aIIbb3, and for technical ease of
crosslinking. Previous studies showed that kindlin-3 overex-
pression increased 3FN(7–10) (seventh to tenth type III fibro-
nectin repeats) [11] binding to integrin a5b1 in RAW264.7 cells.
In contrast to 3FN10, 3FN(7–10) contains a free cysteine [46]
and two integrin binding sites, one in 3FN9 and the other in
3FN10 [47], and is thus not monovalent. In addition, there
may be cell-specific, kindlin-specific, and integrin-specific
mechanisms of regulation, as (1) kindlin-1 and kindlin-2 syner-
gize with THD to activate aIIbb3 but inhibit THD-induced a5b1
activation in CHO cells [22]; (2) overexpressed kindlin-3 is
functional in RAW 264.7 cells, but not in CHO cells [11]; and
(3) kindlin-3 is required for aLb2- but not a4b1-increased cell
adhesiveness under fluid shear stresses [9]. Secondary
antibodies can oligomerize monovalent PAC1 Fab under
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Figure 3. Kindlins Promote Clustering of Occupied Integrins
(A) Cells expressing aIIb-GFPb3 transducedwith lentivirus encoding both kindlin-2 shRNA and DsRedweremixed with uninfected cells and plated on fibrin-
ogen-coated coverslips. The left panels are TIRF images of the distribution of aIIb-GFPb3 at the cell-substrate interface in uninfected cells (DsRed negative)
and shRNA-transduced cells (DsRed positive, white arrows). DsRed epi-illuminated fluorescence images in themiddle panel indicate shRNA lentiviral trans-
duction. GFP epi-illuminated fluorescence images in the right panels indicate comparable aIIbb3 fluorescence in uninfected control cells and kindlin-2
shRNA-expressing cells. Scale bar represents 10 mm.
(B) Fluorescence intensities of integrin puncta were measured and averaged as described in the Supplemental Information. Error bars indicate SEM of n =
1,223, 1,204, and 1,008 puncta in uninfected cells or those transduced with kindlin-2 shRNA1 or shRNA2, respectively.
(C) Cells from the experiment depicted in (A) were stained with anti-aIIbb3 (D57) and analyzed by FACS to assess aIIbb3 surface expression. Data are
expressed as percent of aIIbb3 expressed in control shRNA-infected cells. Error bars indicate 6SEM of three independent experiments.
(D) DsRed-positive shRNA-transduced cells were isolated by FACS, and kindlin-2 expression was assessed by western blotting.
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2292appropriate conditions, converting it into a multivalent ligand
[19]. We formaldehyde fixed the cells before adding secondary
antibody or streptavidin, as recommended by Bunch [19], to
avoid potential oligomerization of the 3FN10. Indeed, when
highly concentrated PAC1 Fab was used to overcome its low
affinity as a monovalent ligand [19], we obtained results com-
parable to those using 3FN10 (Figure 1B). Thus, when sec-
ondary antibody-induced oligomerization is avoided, kindlins
have little effect on the binding of an authentic monovalent
ligand to integrin aIIbb3.
Reduced soluble ligand binding alone might not account for
the defective platelet aggregation and increased bleeding
observed in kindlin-3 null mice and patients. The combined
effects of reduced surface integrin expression [11], defective
integrin clustering, and impaired integrin outside-in signaling
[10–12, 43] may all make important contributions to the hemo-
static defect. Similarly, the effect of kindlin-mediated clus-
tering on avidity can be a major contributor to kindlin-3’s
capacity to support the function of b1 or b2 integrins thatmediate increased resistance of leukocytes to detachment
under flow [8, 48, 49]. Kindlin-mediated leukocyte arrest is
associated with an additional conformational change in aLb2
that can be driven by shear stress on the integrin [9, 49].
Thus, in addition to effects on soluble ligand binding, it is clear
that kindlin-3 makes multiple contributions to the adhesive
functions of blood cells.
Integrin-bound kindlins might promote integrin clustering by
redistributing integrins between different pools, such as those
on the cell surface, in storage pools, and in recycling pathways
[50, 51]. Indeed, loss of kindlin-3 is associated with reduced
aIIbb3 surface expression in murine platelets by about 25%
([11] and our unpublished data), and overexpression of kind-
lins can increase integrin expression in a CHO cell clone [22].
Alternatively, kindlins can recruit migfilin [43] and integrin-
linked kinase (ILK) [12] to occupied integrins, thereby enabling
the further recruitment of actin-binding proteins such as
filamins, PINCHs, and parvins [52] that could promote
cooperative integrin clustering. Kindlins can also bind to
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Figure 4. Loss of Kindlin-2 Reduces Clustering of aIIbb3 Integrins
(A) Electron microscopy (EM) images of colloidal gold-labeled aIIbb3 in adherent cell ventral membrane. CHO cells stably expressing aIIbb3 were trans-
duced with lentivirus expressing control shRNA or kindlin-2 shRNA1, adhered to fibrinogen-coated EM grids, swollen in a hypotonic buffer, and subjected
to a flowof low-salt buffer to remove the cell body. The remaining ventral membrane sheet was stainedwith an anti-b3 tail antibody followed by colloidal gold
adsorbed 2 antibody. Left, middle, and right columns are control shRNA cells, kindlin-2 knockdown cells, and irrelevant IgG-stained control shRNA cells at
differing magnifications. Many clusters of colloidal gold containing more than five particles per cluster are present in control shRNA cells, and such clusters
are absent in kindlin-2-silenced cells. Red circles indicate examples of integrin clusters. Scale bars represent 200 nm for the images in top and middle row
and 2 mm for the images in bottom row. The images in the middle and lower rows are ventral membranes at different magnifications. Images in the top row
show enlarged views of selected areas from those in the middle row.
(B) Cells in (A) were lysed and analyzed with anti-kindlin-2 or anti-GAPDH by western blotting.
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2293polyphosphoinositides [53–56], thereby localizing integrins in
membrane domains that might favor clustering. The present
work will enable further studies to evaluate the precise roles
of kindlin-binding proteins and phospholipids in the capacity
of kindlins to increase clustering of integrins, thereby enhanc-
ing multivalent ligand binding.
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